Literature DB >> 27516244

Effects of solution conditions on characteristics and size exclusion chromatography of pneumococcal polysaccharides and conjugate vaccines.

Mahsa Hadidi1, John J Buckley2, Andrew L Zydney3.   

Abstract

Molecular properties of bacterial polysaccharides and protein-polysaccharide conjugates play an important role in the efficiency and immunogenicity of the final vaccine product. Size exclusion chromatography (SEC) is commonly used to analyze and characterize biopolymers, including capsular polysaccharides. The objective of this work was to determine the effects of solution ionic strength and pH on the SEC retention of several capsular polysaccharides from S. pneumoniae bacteria in their native and conjugated forms. The retention time of the charged polysaccharides increased with increasing ionic strength and decreasing pH due to compaction of the polysaccharides associated with a reduction in the intramolecular electrostatic interactions. The calculated radius of gyration was in good agreement with model calculations based on the worm-like chain model accounting for the increase in chain stiffness and excluded volume of the charged polysaccharide at low ionic strength. These results provide important insights into the effects of solution ionic strength on physical properties and SEC behavior of capsular polysaccharides and their corresponding conjugates.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Capsular polysaccharide; Ionic strength; Pneumococcus; Protein-polysaccharide conjugates; Size exclusion chromatography; Vaccines

Mesh:

Substances:

Year:  2016        PMID: 27516244     DOI: 10.1016/j.carbpol.2016.06.095

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  1 in total

1.  O-acetylation of typhoid capsular polysaccharide confers polysaccharide rigidity and immunodominance by masking additional epitopes.

Authors:  Krisztina Hitri; Michelle M Kuttel; Gianluigi De Benedetto; Kay Lockyer; Fang Gao; Peter Hansal; Timothy R Rudd; Emma Beamish; Sjoerd Rijpkema; Neil Ravenscroft; Barbara Bolgiano
Journal:  Vaccine       Date:  2019-05-31       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.